Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pharmacokinetics of rifapentine and isoniazid in pediatric Thai patients with latent tuberculosis infection
TCTR20190423002Phase 4Not yet recruiting
- Sponsor
- Health Services Research Institute
- Start
- Jun 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of rifapentine, isoniazid in latent tuberculosis infection (LTBI), sponsored by Health Services Research Institute. Planned start Jun 2019; status: not yet recruiting.
02
Drugs
rifapentineisoniazid
03
Conditions
latent tuberculosis infection (LTBI)
Beyond the preview
Go deeper on TCTR20190423002.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20190423002.